These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21732946)

  • 21. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
    Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of metalloproteinases and their tissue inhibitors in inflamed gingival biopsies.
    Gonçalves LD; Oliveira G; Hurtado PA; Feitosa A; Takiya CM; Granjeiro JM; Trackman PC; Otazú I; Feres-Filho EJ
    J Periodontal Res; 2008 Oct; 43(5):570-7. PubMed ID: 18624953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteolytic roles of matrix metalloproteinase (MMP)-13 during progression of chronic periodontitis: initial evidence for MMP-13/MMP-9 activation cascade.
    Hernández Ríos M; Sorsa T; Obregón F; Tervahartiala T; Valenzuela MA; Pozo P; Dutzan N; Lesaffre E; Molas M; Gamonal J
    J Clin Periodontol; 2009 Dec; 36(12):1011-7. PubMed ID: 19929954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissue.
    Lichtinghagen R; Musholt PB; Stephan C; Lein M; Kristiansen G; Hauptmann S; Rudolph B; Schnorr D; Loening SA; Jung K
    Anticancer Res; 2003; 23(3B):2617-24. PubMed ID: 12894549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gingival crevicular fluid levels of MMP-8, MMP-9, TIMP-2, and MPO decrease after periodontal therapy.
    Marcaccini AM; Meschiari CA; Zuardi LR; de Sousa TS; Taba M; Teofilo JM; Jacob-Ferreira AL; Tanus-Santos JE; Novaes AB; Gerlach RF
    J Clin Periodontol; 2010 Feb; 37(2):180-90. PubMed ID: 19995403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis.
    Górska R; Nedzi-Góra M
    Arch Immunol Ther Exp (Warsz); 2006; 54(6):419-26. PubMed ID: 17122880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of selective COX-2 inhibitor/celecoxib and omega-3 fatty acid on matrix metalloproteinases, TIMP-1, and laminin-5gamma2-chain immunolocalization in experimental periodontitis.
    Vardar-Sengul S; Buduneli E; Turkoglu O; Buduneli N; Atilla G; Wahlgren J; Sorsa T; Baylas H
    J Periodontol; 2008 Oct; 79(10):1934-41. PubMed ID: 18834249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
    Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substance P regulates the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in cultured human gingival fibroblasts.
    Cury PR; Canavez F; de Araújo VC; Furuse C; de Araújo NS
    J Periodontal Res; 2008 Jun; 43(3):255-60. PubMed ID: 18179473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
    Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
    Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].
    Fan SQ; Wei QY; Li MR; Zhang LQ; Liang QC
    Ai Zheng; 2003 Sep; 22(9):968-73. PubMed ID: 12969531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinase-7, -8, -9, -25, and -26 and CD43, -45, and -68 cell-markers in HIV-infected patients' saliva and gingival tissue.
    Mellanen L; Lähdevirta J; Tervahartiala T; Meurman JH; Sorsa T
    J Oral Pathol Med; 2006 Oct; 35(9):530-9. PubMed ID: 16968233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
    Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
    Pesta M; Topolcan O; Holubec L; Rupert K; Cerna M; Holubec LS; Treska V; Finek J; Cerny R
    Anticancer Res; 2007; 27(4A):1863-7. PubMed ID: 17649785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enamel matrix derivative induces the expression of tissue inhibitor of matrix metalloproteinase-3 in human gingival fibroblasts via extracellular signal-regulated kinase.
    Zeldich E; Koren R; Dard M; Weinberg E; Weinreb M; Nemcovsky CE
    J Periodontal Res; 2010 Apr; 45(2):200-6. PubMed ID: 19909407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
    Andrian E; Mostefaoui Y; Rouabhia M; Grenier D
    J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia].
    Zhang H; Lin QD; Qiao C
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):509-13. PubMed ID: 17083831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.